Features of 18F-FDG-PET/CT imaging with some histopathological types of non-Hodgkin's lymphoma at Bach Mai Hospital in the period 2017-2022
Main Article Content
Abstract
Objective: Description of 18F-FDG-PET/CT imaging characteristics and Comment on the correlation of 18F-FDG-PET/CT images with some histopathological types of non-Hodgkin's lymphoma.Subjects and methods: Cross-sectional, retrospective and prospective descriptive study in 286 patients with non-Hodgkin's lymphoma were newly diagnosed and treated at Bach Mai Hospital.Results: Lymph node involvement for 84.3%, extra-nodal lesions for 54.5%. Patients only had lymph node lesions for 45.5%, only extranodal lesions accounted for 15.7% and mixed lymph node and extranodal lesions accounted for 38.8%. Common extranodal lesions are bone (18.4%), tonsils (17.7%), spleen (11.7%), nasopharynx (8.5%), stomach (8.2%), nasal cavity (7.8%), lung (5.3%), adrenal gland (4.3%), colorectal (3.9%), liver (3.7%), soft tissue (2 0.8%), brain (2.1%). Bulky lesions in 22.7% lymph node locations, 19.3% extranodal location. There is a positive linear correlation between lesion size and SUVmax in cervical, axillary, mediastinal, abdominal and inguinal nodes with the corresponding correlation coefficient r: 0.47; 0.51; 0.41; 0.46 and 0.56. There is a positive linear correlation between lesion size and SUVmax in tonsil, nasopharynx, nose, stomach, colorectal, liver, lung and adrenal gland with the corresponding correlation coefficient r: 0.60 ; 0.44; 0.38; 0.64; 0.86; 0.54; 0.44 and 0.78. There was no difference in size and SUVmax of lymph node and extranodal lesions and the proportion of bulky tumors in diffuse large B cells lymphoma’s subtypes GCB and nonGCB. B cells non Hodgkin lymphoma group progressed slowly compared to fast progress: there was a higher difference in the size of abdominal lymph nodes in the rapidly progressing group (p<0.05); There was a difference in SUVmax values of cervical, mediastinal, abdominal, and extra-nodal lesions in group B cells lymphoma that progressed faster with p<0.05. T cells non Hodgkin lymphoma group: Peripheral T, T/NK, aplastic T have differences in size, SUVmax with cervical lymph node damage, extranodal injury, bone (with p<0.05); There was a difference between group T peripheral lower than T anaplastic in size, SUVmax axillary, abdominal, inguinal (p<0.05) and SUVmax mediastinal lymph node (p<0.05). The group with high, medium and low Ki76 index had a difference in SUVmax in cervical, abdominal and extra-nodal lesions (p<0.05) although there was no difference in lesion size (p> 0.05).Conclusions: Study on 286 non Hodgkin lymphoma patients: lymphadenopathy in 84.3%; Extra-nodal lesions in 54.5% (mixed lesions of both lymph nodes and extra-nodals in 38.8%). There is a positive linear correlation between lesion size and SUVmax in lymph nodes and extranodal lesions. There was no difference in size and SUVmax of lymph node and extranodal lesions and the prevalence of bulky tumors, diffuse large B cells lymphoma subtypes GCB and nonGCB. There was a difference in size and maxSUV value of lesions at some sites in the lymph nodes and in extra-nodal nodes in the group with slow progression compared to the fast progression B cell group, the T cells group, the high ki67 group.
Keywords
Non Hodgkin lymphoma, PET/CT, correlation, histopathology, imaging.
Article Details
References
lympho ác tính không Hodgkin vùng đầu cổ. Tạp chí khoa học công nghệ Việt Nam. 62(5) 5.2020.
2. Nguyễn Bá Đức, Đỗ Anh Tú, Nguyễn Tuyết Mai, Vũ Quang Toản. 2006. Nghiên cứu đặc điểm lâm sàng và kết quả bước đầu điều trị bệnh u lymphô ác tính không Hodkin ngoài hạch vùng đầu cổ tại Bệnh viện K. Tạp chí Y học Việt Nam tr54-59.
3. Jayanta Das, Soumendranath Ray, Saugata Sen et al. Extranodal involvement in lymphoma – A Pictorial Essay and Retrospective Analysis of 281 PET/CT studies. Asia Ocean J Nucl Med Biol. 2014 Spring; 2(1): 42–56.
4. Nguyễn Văn Mão. 2016. Nghiên cứu đặc điểm mô bệnh học ở bệnh nhân U lympho ác tính Hodgkin và không Hodgkin. Tạp chí Y dược học, Tập 6 (03); Trang 54-9.
5. Galal Alobthani, Victor Romanov, Kayako Isohashi et al. 2018. SUVmax cut-off between aggressive and indolent non-Hodgkin lymphoma in nontime of flight FDG PET/CT and time of flight FDG PET/CT. Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1419.
6. Gerhard Held , Niels Murawski , Marita Ziepert et al. Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell Lymphoma. Journal of Clinical Oncology, Volume 32, Issue 11.
7. Christine P Hans et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004 Jan 1;103(1):275-82.
8. Einat Even-Sapir, Genady Lievshitz, Chava Perry et al. Fluorine-18 fluorodeoxyglucose PET/CT
patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin’s disease. Radiol Clin North Am. 2007 Jul;45(4):697-709, vii.
9. Adi Broyde et al . Role and prognostic significance of the Ki-67 index in non-Hodgkin’s lymphoma. Am J Hematol. 2009 Jun;84(6):338-43.
10. Xin He, Zhigang Chen, Tao Fu et al. Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis. 2014 BMC Cancer. 2014; 14: 153.